Skip to content

Dr. Kathleen Joos

Active Private limited companyfounded 2021active for 5 yearsVinkendreef 5, 2460 KasterleeKBO/BCE: BE 0767.695.216 #9 company by equity in Kasterlee, Health and social work sector

Lifetime

4 annual accounts with figures on one time axis
peak of €573,696 in 2022
€514,812▲ 2.6%
peak of €395,791 in 2025
€395,791▲ 5.8%
peak of €1.0m in 2024
€728,556▼ 27.6%
€7,754▲ 113%
Board1 name since 2021
- 
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Registered office moved from Geel to Kasterlee 08-04Dividend €674,064Equity from €1.0m to €728,556Debts from €3,645 to €7,754Cash from €574,808 to €392,999

Key points

from the 2025 annual accounts

Equity

€728,556 ▼ 27.6%
1.02024+0.4Profit-0.7Dividend0.72025

Dr. Kathleen Joos paid out €674,064 in dividends. That is 170% of the 2025 profit.

Turnover

≈ €770,000 estimated

The micro format states no turnover.

Position in the sector

98.9%

Higher solvency than 95% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,785 companies had the same profile as Dr. Kathleen Joos has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,785 companies, not a prediction for Dr. Kathleen Joos. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

  • 5,000 sharesdeed of 04-05-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0767695216
Registered office moved from Geel to Kasterlee The registered office moved from Brabantsblok 13, 2440 Geel to Vinkendreef 5, 2460 Kasterlee · Gazette deed
Incorporation Founding capital of €5,000, 5,000 shares · Founded by · appointed as statutory director · published on 04-05-2021 · Gazette deed
2 establishments registered Geel and Genk
All 13 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Kathleen Joos Kasterlee €736,310 €514,812 98.9% -
Dr. Caroline Janssen Oud-Turnhout €758,251 €548,679 42.3% -
Sophie Bataillie Zandhoven €752,485 €551,035 65.7% -
Dr. Mathias Van Tornout Bruges €720,040 €487,518 0.7% -
Dr. Ann-Sofie Schauwvlieghe - Oogarts Destelbergen €787,344 €498,347 60.3% -
Dr. Vanhonsebrouck Eva Bruges €716,597 €582,522 2.4% -
Dr. F. Decuypere, Plastisch chirurg Oostkamp €829,762 €548,305 0.3% -

These companies have the same main activity as Dr. Kathleen Joos: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €717,000 and €830,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 30-04-2021Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.316.960.1132440 Geel, since 30-04-2021
2.316.960.2123600 Genk, since 30-04-2021
Financial year end
31 December
Peppol
Reachable since 25-06-2025
Company details

Annual accounts 2025

€736,310▼ 27.1%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on Dr. Kathleen Joos

Dr. Kathleen Joos files the micro format. That format states no turnover. The gross margin fell from €573,696 in 2022 to €514,812 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Kathleen Joos

What is the company number of Dr. Kathleen Joos?
The company number of Dr. Kathleen Joos is 0767.695.216. The VAT number is the same number with BE in front: BE 0767.695.216.
Where is Dr. Kathleen Joos based?
The registered office is at Vinkendreef 5, 2460 Kasterlee.Company details
What does Dr. Kathleen Joos do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Kathleen Joos?
Dr. Kathleen Joos is a private limited company (BV).
When was Dr. Kathleen Joos founded?
Dr. Kathleen Joos was founded on 30-04-2021.
Is Dr. Kathleen Joos still active?
Yes, Dr. Kathleen Joos is an active enterprise in the KBO register.
What is the turnover of Dr. Kathleen Joos?
The turnover in financial year 2025 is about €770,000. This figure is estimated from the gross margin of €514,812 and 31 comparable companies (NACE 86220). It probably lies between €690,000 and €1.1m.Financials
Is Dr. Kathleen Joos profitable?
In financial year 2025, Dr. Kathleen Joos made a profit of €395,791.
Where can I find the annual accounts of Dr. Kathleen Joos?
Dr. Kathleen Joos filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Kathleen Joos due?
Dr. Kathleen Joos must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.